United Therapeutics, a biotechnology company with co-headquarters and manufacturing facilities in Research Triangle Park, has acquired a Boston-area biotech company to boost its efforts in ...
Mary-Dell Chilton, Ph.D., an American pioneer in plant sciences known as the “Queen of the Agrobacterium,” died on June 24, ...
Lauri Andrews is a career coach and former recruiting leader with more than 35 years of experience helping people navigate career transitions and professional growth.
The U.S. Food and Drug Administration selected three biopharma companies with manufacturing sites in North Carolina for a ...
Two life sciences organizations with operations in North Carolina are planning major expansions that will bring over 1,500 jobs and $1.8 billion in investment to the Greater Charlotte region.
Diazyme Laboratories, Inc. has acquired the business of Carolina Liquid Chemistries Corporation (CLC). CLC is an FDA-registered manufacturer and value-added reseller of chemistry systems and reagents.
Join Noverant on August 6 for an interactive lunch and learn focused on practical approaches to automating validation for 21 CFR Part 11 regulated software applications. Designed for both growing ...
Venture Connect serves as the primary connector for tech and biotech companies in the Southeast that are seeking capital and other resources to accelerate their growth. This two-day event is designed ...
In the largest capital investment ever in North Carolina’s life sciences, Novo Nordisk plans to invest $4.1 billion to expand its fill and finish operations in Johnston County, creating 1,000 new jobs ...
Two pharmaceutical companies with operations in North Carolina are joining forces for a greater impact on women’s health. Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical ...
Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced formation of what they deem “the first AI-powered cell manufacturing platform,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results